These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1305425)

  • 1. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bizerine: new anticholinesterase drug with selective gastrointestinal action].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Shchemeleva NI
    Eksp Klin Farmakol; 2010 Aug; 73(8):14-6. PubMed ID: 20919551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB; Sazonova AV
    Eksp Klin Farmakol; 1995; 58(5):57-61. PubMed ID: 8704593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
    Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET
    Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New data on the pharmacokinetics of aminostigmine].
    Prozorovskiĭ VB; Chepur SV; Vorob'ev-Desiatovskiĭ NV; Panov PB
    Eksp Klin Farmakol; 1998; 61(5):46-9. PubMed ID: 9854634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB; Iudkina NI
    Anesteziol Reanimatol; 1991; (1):25-6. PubMed ID: 1862957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB; Skopichev VG; Ditiateva ZhA; Sazonova AV
    Eksp Klin Farmakol; 2000; 63(4):64-7. PubMed ID: 11022312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aminostigmine-a novel drug against home poisoning].
    Bonitenko II; Safronov GA; Sosiukin AE; Pershin VN; Shpilenia LS
    Klin Med (Mosk); 1996; 74(8):58-61. PubMed ID: 9036214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Kokushkina AV
    Vopr Med Khim; 1999; 45(6):525-9. PubMed ID: 10761219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
    Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L
    Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cholinesterase from different sources by 3-diethylaminophenyl-N-methylcarbamate methiodide in vitro.
    Bajgar J; Patocka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(5):597-602. PubMed ID: 6599176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of anticholinesterase activity and the effectiveness of anticholinesterase substances].
    Prozorovskĭ VB; Artem'ev VS; Tonkopiĭ VD; Konstorum MG
    Farmakol Toksikol; 1975; 38(4):402-6. PubMed ID: 1213123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity.
    Cook WO; Beasley VR; Dahlem AM; Dellinger JA; Harlin KS; Carmichael WW
    Toxicon; 1988; 26(8):750-3. PubMed ID: 3188065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
    Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinesterase effect of sotalol.
    Alkondon M; Sivam SP; Bhatia S; Sen P
    Indian J Med Res; 1981 May; 73():796-800. PubMed ID: 6114921
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between cholinesterase activity and brain permeability to barbitone.
    Rosić N; Milosević MP
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):302-7. PubMed ID: 6047617
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological characteristics of desoxypeganine hydrochloride].
    Tuliaganov N; Sadritdinov FS; Suleĭmanova GA
    Farmakol Toksikol; 1986; 49(3):37-40. PubMed ID: 3720932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the role of the brain cholinergic system in the mechanisms of dissociative learning.
    Azarashvili AA
    Neurosci Behav Physiol; 1997; 27(4):341-6. PubMed ID: 9252989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.